Take Control of Your AML Journey with Advanced MRD Monitoring
When you’re navigating acute myeloid leukaemia treatment, uncertainty can be one of the most challenging aspects of your journey. The AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor provides the precise, reliable monitoring you need to feel confident about your treatment progress and long-term health outcomes.
Understanding Your MRD Monitoring Test
This sophisticated test uses Real-Time PCR technology to detect and quantify the specific genetic rearrangement associated with AML ETO t(8;21). Unlike standard tests that might miss small amounts of residual disease, our MRD monitor can identify even minute quantities of leukaemia cells – giving you and your healthcare team the most accurate picture of your treatment response.
Think of it as an early warning system that helps detect potential relapse before symptoms appear, allowing for timely intervention and better treatment outcomes.
Who Should Consider This Essential Monitoring Test?
This test is particularly important for:
- Patients diagnosed with AML ETO t(8;21) undergoing treatment
- Individuals in remission who want ongoing monitoring for early relapse detection
- Patients experiencing concerning symptoms like unexplained fatigue, bruising, or recurrent infections
- Those whose treatment response needs precise quantification
- Patients preparing for or recovering from stem cell transplantation
If you’re feeling anxious about whether your treatment is working effectively, this test provides the objective data you need for peace of mind.
Why This Monitoring Matters for Your Health Journey
Early detection of minimal residual disease can significantly impact your treatment success and quality of life. Benefits include:
- Early Intervention: Detect potential relapse months before symptoms appear
- Treatment Guidance: Help your medical team adjust therapy based on precise data
- Peace of Mind: Reduce anxiety with clear, quantitative results
- Better Outcomes: Early detection leads to more effective treatment responses
- Personalised Care: Tailor your treatment plan based on your specific genetic profile
Understanding Your Results with Confidence
Your results will provide clear, quantitative data about the presence and amount of residual leukaemia cells. Our expert haematologists will help interpret what these numbers mean for your specific situation. Remember – detectable MRD doesn’t necessarily mean treatment failure, but it provides crucial information for optimising your care plan.
We provide comprehensive reports that your healthcare team can use to make informed decisions about your ongoing treatment and monitoring schedule.
Transparent Pricing – Exceptional Value for Your Health
| Test Description | Regular Price | Special Price | Savings |
|---|---|---|---|
| AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor | ZAR 2,500 | ZAR 850 |
This special pricing represents exceptional value for advanced genetic monitoring that could significantly impact your treatment outcomes.
Why Trust Oracle Genomics for Your MRD Monitoring?
At Oracle Genomics, we understand that trust is earned through consistent accuracy and compassionate care:
- Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, and Pretoria
- Expert Analysis: Results interpreted by specialist haematologists
- Rapid Turnaround: Sample collection Monday/Thursday by 11am; Reports available Wednesday/Saturday
- Advanced Technology: State-of-the-art Real-Time PCR methodology
- Patient-Focused: Empathetic support throughout your testing journey
Sample Requirements
5 mL (3 mL minimum) whole blood or bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled MRD Requisition form (Form 22) with historical data is mandatory for accurate interpretation.
Take the Next Step in Your Health Journey Today
Don’t let uncertainty about your treatment response create unnecessary stress. Early detection through MRD monitoring can make a significant difference in your treatment outcomes and peace of mind.
Limited Time Offer: This special pricing of ZAR 2,500 (regularly ZAR 3,350) represents significant savings on advanced genetic monitoring that could be crucial for your treatment success.
“Knowledge is power when facing leukaemia. This test gave me the confidence that my treatment was working and peace of mind during my recovery.” – Oracle Genomics Patient
